Review
Open access
Jul 2026
New therapeutic target for osteoarthritis: modulating immune-metabolic aberrations and micromilieu remodeling in underlying bone
Results support the idea that OA is an immunometabolic disease, and it is anticipated that this approach will control the immunometabolic dialogue, slow the advancement of osteoarthritis, end the vicious cycle of inflammatory metabolic disorders, and ultimately offer a new approach to treating osteoarthritis.
Ying Gao, Lan Shen, Xiaomei Su et al.
· Frontiers in Pharmacology · 0 citations